logo
  

Amedisys Inc. (AMED) Broke Out To A New High After Q3 Profit Beat Expectations

Amedisys Inc. (AMED) reported third quarter EPS of $0.26 Wednesday morning, compared to the loss of $2.89 in the previous year. The consensus estimate was for EPS of $0.15.

Amedisys gapped open sharply higher Wednesday and posted gains in early trade, before settling into a range. The stock ended the day higher by 3.46 at $25.22 on above average volume. Amedisys broke out of a 3-month range and set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.

Jobless claims data was the highlight in this relatively light week for U.S. economics. In Europe, focus was on the U.K. economy where the Bank of England announced its latest policy decision and the first quarter GDP data were released. Find out the signals from the central bank and whether or not the UK economy exited a recession. In the Asia-Pacific, Australia's central bank delivered its latest policy verdict and China released trade figures.

View More Videos
Follow RTT